Literature DB >> 26951100

Immunology of Chronic Obstructive Pulmonary Disease and Sulfur Mustard Induced Airway Injuries: Implications for Immunotherapeutic Interventions.

Yunes Panahi, Farhad Jadidi-Niaragh, Sadegh Azimzadeh Jamalkandi, Mostafa Ghanei1, Claudio Pedone, Nazila Nikravanfard, Farzaneh Nikravesh, Amirhossein Sahebkar2.   

Abstract

BACKGROUND: Sulfur mustard (SM)-induced airway injuries and chronic obstructive pulmonary disease (COPD) are characterized by chronic inflammation of the respiratory tract and share some similarities regarding the cellular and molecular mechanisms orchestrating airway destruction. Since available data regarding the immunobiology of COPD is much more known compared with SM-mediated injuries, and considering the similarities in the immunopathogenesis of these diseases, comparison of the immunopathogenesis of COPD and SM-induced respiratory complications can help designing new therapeutic approaches for treatment of SM-induced injuries.
METHODS: A multi-database search was performed to identify articles dealing with the role of immune system function in the pathogenesis of COPD and mustard mustard-induced respiratory complications.
RESULTS: This review outlines the role of different components of the immune system in the pathogenesis of COPD and mustard-induced respiratory complications, and suggests therapeutic implication for improving the management of the latter condition as the most common chronic complication of sulfur mustard exposure.
CONCLUSION: Although COPD and mustard lung are overlapping phenotypes and have shared pathophysiologic features, there are certain differences between these two diseases that necessitate further scrutiny. Combination therapies to counterbalance inflammation, oxidative stress and immune imbalance hold promise for the management of SM-induced respiratory complications but the success of such combined treatments need to be confirmed in proof-ofconcept trials.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26951100     DOI: 10.2174/1381612822666160307150818

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  4 in total

1.  Editorial: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases.

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

2.  Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C)).

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

3.  Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part B).

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 4.  Risks of on-pump coronary artery bypass grafting surgery in patients with chronic obstructive pulmonary disease due to sulfur mustard.

Authors:  Mehdi Dehghani Firoozabadi; Mohammad Ali Sheikhi; Hossein Rahmani; Ahmad Ebadi; Amanollah Heidari; Behnam Gholizadeh; Khosrow Sharifi
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.